How To Use CPT Code 3750F

CPT 3750F describes the circumstances in which a provider does not administer corticosteroid medication at a dose greater than or equal to 10 mg per day for 60 or more consecutive days in a patient with inflammatory bowel disease. This article will cover the description, official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 3750F?

CPT 3750F can be used to describe the situation in which a provider does not administer corticosteroid medication at a dose greater than or equal to 10 mg per day for 60 or more consecutive days in a patient with inflammatory bowel disease. This code is used when the provider opts for corticosteroid sparing therapy, such as immunomodular drugs, instead of corticosteroid treatment.

2. Official Description

The official description of CPT code 3750F is: ‘Patient not receiving dose of corticosteroids greater than or equal to 10 mg/day for 60 or greater consecutive days (IBD).’ There are no additional notes available for this code.

3. Procedure

1. The provider assesses the patient’s condition and determines the appropriate treatment plan for their inflammatory bowel disease.
2. If corticosteroid therapy is deemed necessary, the provider may prescribe a dose greater than or equal to 10 mg per day for 60 or more consecutive days.
3. If the provider decides to pursue corticosteroid sparing therapy, such as immunomodular drugs, they will not administer corticosteroids at the specified dose and duration.
4. The provider documents the patient’s treatment and the date in the patient’s healthcare record.

4. Qualifying circumstances

Patients eligible for CPT 3750F are those with inflammatory bowel disease, specifically ulcerative colitis or Crohn’s disease, who do not receive corticosteroid medication at a dose greater than or equal to 10 mg per day for 60 or more consecutive days. This code is used when the provider opts for corticosteroid sparing therapy, such as immunomodular drugs, instead of corticosteroid treatment.

5. When to use CPT code 3750F

CPT code 3750F should be used when the provider does not administer corticosteroid medication at a dose greater than or equal to 10 mg per day for 60 or more consecutive days in a patient with inflammatory bowel disease. This code should not be used if the provider prescribes corticosteroids at the specified dose and duration.

6. Documentation requirements

To support a claim for CPT 3750F, the provider must document the following information:

• Patient’s diagnosis of inflammatory bowel disease
• Decision to pursue corticosteroid sparing therapy
• Date of the decision
• Documentation of the patient’s treatment plan

7. Billing guidelines

When billing for CPT 3750F, ensure that the provider does not administer corticosteroid medication at a dose greater than or equal to 10 mg per day for 60 or more consecutive days in a patient with inflammatory bowel disease. This code should not be reported if corticosteroids are prescribed at the specified dose and duration. There are no specific guidelines regarding reporting this code with other codes.

8. Historical information

CPT 3750F was added to the Current Procedural Terminology system on January 1, 2013. There have been no updates to the code since its addition.

9. Examples

1. A gastroenterologist decides to prescribe immunomodular drugs instead of corticosteroids at a dose greater than or equal to 10 mg per day for 60 or more consecutive days for a patient with ulcerative colitis.
2. A provider opts for corticosteroid sparing therapy for a patient with Crohn’s disease, choosing not to administer corticosteroids at the specified dose and duration.
3. A patient with inflammatory bowel disease is not prescribed corticosteroids at a dose greater than or equal to 10 mg per day for 60 or more consecutive days, as the provider deems it unnecessary for their condition.
4. A gastroenterologist decides to use alternative treatments for a patient with ulcerative colitis, avoiding the use of corticosteroids at the specified dose and duration.
5. A provider chooses not to administer corticosteroids at a dose greater than or equal to 10 mg per day for 60 or more consecutive days for a patient with Crohn’s disease, opting for other treatment options.
6. A patient with inflammatory bowel disease does not receive corticosteroids at the specified dose and duration, as the provider believes it is not the most suitable treatment for their condition.
7. A gastroenterologist prescribes immunomodular drugs instead of corticosteroids at a dose greater than or equal to 10 mg per day for 60 or more consecutive days for a patient with Crohn’s disease.
8. A provider chooses not to administer corticosteroids at the specified dose and duration for a patient with ulcerative colitis, opting for corticosteroid sparing therapy.
9. A patient with inflammatory bowel disease is not prescribed corticosteroids at a dose greater than or equal to 10 mg per day for 60 or more consecutive days, as the provider believes it is not the most effective treatment option.
10. A gastroenterologist decides to pursue corticosteroid sparing therapy for a patient with Crohn’s disease, avoiding the use of corticosteroids at the specified dose and duration.